The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Effect of naloxone therapy on depersonalization: a pilot study
Abstract
To test the hypothesis of the role for the opioid system in the pathogenesis of depersonalization, the effect of naloxone (an opioid receptor blocker) on the symptoms and corticosteroids secretion was studied in patients with depersonalization syndrome. Fourteen depersonalization patients were treated with naloxone: 11 patients received single doses (1.6 or 4 mg i.v.) and three others received multiple infusions, with the maximal dosage being 10 mg, and the effect of naloxone on symptom severity was determined. In eight patients, the cortisol, cortisone and corticosterone content in the blood plasma was determined prior to and after the 4 mg naloxone infusion. A reversed-phase microcolumn high-performance liquid chromatography with ultraviolet detection was applied for assessment of glucocorticoids. In three of 14 patients, depersonalization symptoms disappeared entirely and seven patients showed a marked improvement. The therapeutic effect of naloxone provides evidence for the role of the endogenous opioid system in the pathogenesis of depersonalization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Only two medications have performed better than placebo for treatment of dissociative symptoms in RCTs: the opioid antagonist naloxone and the SSRI paroxetine.”
From Treatment of dissociative identity disorder: leveraging neurobiology to optimize success (2024) · cites this paper as [115]
In the citing paper
“One single blind placebo-controlled trial found the opiate antagonist, naloxone, reduced depersonalization symptoms in depersonalization disorder [115].”
From Treatment of dissociative identity disorder: leveraging neurobiology to optimize success (2024) · cites this paper as [115]
In the citing paper
“Finally, a handful of studies report successful reductions in dissociative symptoms, including depersonalization, following treatment with opioid-receptor antagonists (e.g., naloxone and naltrexone) among individuals with depersonalization disorder (Nuller et al., 2001;Simeon and Knutelska, 2005), and BPD (Bohus et al., 1999;Schmahl et al., 2012; but see Philipsen et al., 2004).”
From A review of the relation between dissociation, memory, executive functioning and social cognition in military members and civilians with neuropsychiatric conditions (2016) · cites this paper as Nuller et al., 2001
Citations
Cites
Gelder, M. (1983) · Cited by 557
Bridges, P. K. (1990) · Postgraduate Medical Journal · doi:10.1136/pgmj.66.773.255-c · Cited by 172
Opioid peptide and α-adrenoceptor pathways in the regulation of the pituitary-adrenal axis in man
Delitala, G., Trainer, P. J., Oliva, O., Fanciulli, G., & Grossman, A. B. (1994) · Journal of Endocrinology · doi:10.1677/joe.0.1410163 · Cited by 48 · cited 1×
“By blocking the action of endorphins, naloxone increases the cortisol secretion (Delitala et al., 1994).”
BackgroundBehavioral effects of naloxone infusion in obsessive-compulsive disorder
Keuler, D. J., Altemus, M. M., Michelson, D., Greenberg, B. D., & Murphy, D. L. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00632-x · Cited by 45
Multiple hormonal responses to morphine: Relationship to diagnosis and dexamethasone suppression
Bánki, C. M., & Arato, M. Y. (1987) · Psychoneuroendocrinology · doi:10.1016/0306-4530(87)90016-3 · Cited by 38
Depersonalisation: symptoms, meaning, therapy
Nuller, Y. L. (1982) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1982.tb04502.x · Cited by 35
Self-citationNALOXONE AND NALTREXONE IN MENTAL ILLNESS AND TARDIVE DYSKINESIA *
Volavka, J., Anderson, B. C., & Koz, G. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb39480.x · Cited by 18 · cited 2×
“Previous attempts to use naloxone for treating mental disorders proved to be unsuccessful (Abrams et al., 1978; Volavka et al., 1982; Keuler et al., 1996) and an insignificant positive ef fect of short duration was recorded only in case of mania (Janowsky et al.”
BackgroundUnresponsiveness of Catatonic Symptoms to Naloxone
Abrams, A., BRAFF, D. L., Janowsky, D. S., Hall, S., & Segal, D. (1978) · Pharmacopsychiatry · doi:10.1055/s-0028-1094576 · Cited by 12 · cited 2×
“Previous attempts to use naloxone for treating mental disorders proved to be unsuccessful (Abrams et al., 1978; Volavka et al., 1982; Keuler et al., 1996) and an insignificant positive ef fect of short duration was recorded only in case of mania (Janowsky et al.”
BackgroundBehavioral Effects of Opioid Receptor Antagonists in Psychopathologic States
Janowsky, D. S., Judd, L. L., Huey, L. Y., Risch, S. C., & Segal, D. S. (1983) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30814-1 · Cited by 9
Research works printed but not linked: 6
- Abugova M A, 1996, Bekhterev Rev Psychiatry Med Psychol, 4, 120
- American Psychiatric Association, 1994, DSM-lV: diagnostic and statistical manual of mental disorders
- Gamper N L, Proceedings of the 18th International Symposium on capillary chromatography V111, 1655
- Moroz B T, 1990, Zhurnal Nevropatologii Psichiatrii, 90, 81
- Nuller Y L, 1988, Affective psychoses
- Shader R I, 1994, Manuel of psychiatric therapeutics
Cited by
Human blood metabolite timetable indicates internal body time
Kasukawa, T., Sugimoto, M., Hida, A., Minami, Y., Mori, M., Honma, S., Honma, K.-I., Mishima, K., Soga, T., & Ueda, H. R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207768109 · Cited by 211
“Cortisol is a well-known circadian-oscillating metabolite in the blood (11), and cortisone is a direct metabolite of the cortisol also found in the blood (49).”
BackgroundMillière, R. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00245 · Cited by 206
Depersonalisation Disorder: A Contemporary Overview
Simeon, D. (2004) · CNS Drugs · doi:10.2165/00023210-200418060-00002 · Cited by 198
Borderline personality disorder: a dysregulation of the endogenous opioid system?
Bandelow, B., Schmahl, C., Falkai, P., & Wedekind, D. (2010) · Psychological Review · doi:10.1037/a0018095 · Cited by 135
Mula, M., Pini, S., & Cassano, G. B. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.08.025 · Cited by 100
Metadata
- Authors
- Nuller, Y. L., Morozova, M. G., Kushnir, O. N., & Hamper, N.
- Affiliations
- The Psychopharmacological Department, Bekhterev Psychoneurological Research Institute, 3 Bekhterev St, St-Petersburg 193019, Russia;;
- St.Petersburg V.M.Bekhterev Psychoneurological Research Institute (RU)
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2001-03
- Volume
- 15
- Issue
- 2
- Pages
- 93-95
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W1988459373
- Cited by
- 67
- References
- 9
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 5 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 1 · 2017: 5 · 2016: 2 · 2015: 4 · 2014: 3 · 2013: 5 · 2012: 2
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- naloxone, depersonalization, opioid system, endogenous opioids, opioid antagonism, glucocorticoids, cortisol, corticosteroid secretion, symptom severity, pathogenesis
- MeSH terms
- Adult, Chromatography, High Pressure Liquid, Depersonalization, Female, Glucocorticoids, Humans, Male, Naloxone, Narcotic Antagonists, Psychiatric Status Rating Scales, Spectrophotometry, Ultraviolet
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of naloxone therapy on depersonalization: a pilot study. https://app.cochat.ai/papers/10.1177/026988110101500205
- The paper
- Nuller, Y. L., Morozova, M. G., Kushnir, O. N., & Hamper, N. (2001). Effect of naloxone therapy on depersonalization: a pilot study. Journal of Psychopharmacology. https://doi.org/10.1177/026988110101500205
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.